{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:24:52Z","timestamp":1782451492264,"version":"3.54.5"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,15]]},"DOI":"10.1093\/cid\/cix035","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:27:11Z","timestamp":1485782831000},"page":"1059-1065","source":"Crossref","is-referenced-by-count":43,"title":["Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms"],"prefix":"10.1093","volume":"64","author":[{"given":"Ruthiran","family":"Kugathasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami A.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Haddow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"El Bouzidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon G.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cartledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"key\n\t\t\t\t20170522125846_CIT0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jinf.2012.04.007","article-title":"Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting","volume":"65","year":"2012","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170522125846_CIT0002","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s13365-016-0448-1","article-title":"Discordant CSF\/plasma HIV-1 RNA in patients with unexplained low-level viraemia","volume":"22","year":"2016","journal-title":"J Neurovirol"},{"key":"key\n\t\t\t\t20170522125846_CIT0003","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment","volume":"202","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522125846_CIT0004","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522125846_CIT0005","first-page":"101","article-title":"Central nervous system penetration and effectiveness of darunavir\/ritonavir monotherapy","volume":"16","year":"2014","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20170522125846_CIT0006","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00002030-200007280-00014","article-title":"Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir\/saquinavir or ritonavir\/saquinavir\/stavudine","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522125846_CIT0007","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3109\/00365548.2012.690526","article-title":"Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir\/ritonavir monotherapy","volume":"44","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20170522125846_CIT0008","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s13365-013-0175-9","article-title":"CSF viral escape in a patient with HIV-associated neurocognitive disorder","volume":"19","year":"2013","journal-title":"J Neurovirol"},{"key":"key\n\t\t\t\t20170522125846_CIT0009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"CHARTER Group","year":"2008","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170522125846_CIT0010","first-page":"15","article-title":"Penetration and effectiveness of antiretroviral therapy in the central nervous system","volume":"8","year":"2009","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"key\n\t\t\t\t20170522125846_CIT0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QAI.0b013e318274e2b0","article-title":"Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid","volume":"62","author":"Swiss HIV Cohort Study","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522125846_CIT0012","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","article-title":"Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load","volume":"26","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522125846_CIT0013","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s13365-015-0416-1","article-title":"Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study","volume":"22","author":"CHARTER Group","year":"2016","journal-title":"J Neurovirol"},{"key":"key\n\t\t\t\t20170522125846_CIT0014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990\u20131998","volume":"56","author":"Multicenter AIDS Cohort Study","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522125846_CIT0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":"Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group","volume":"42","year":"1997","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170522125846_CIT0016","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":"Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain","volume":"42","year":"1997","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170522125846_CIT0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cyto.2016.04.004","article-title":"CSF\/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF","volume":"83","year":"2016","journal-title":"Cytokine"},{"key":"key\n\t\t\t\t20170522125846_CIT0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13365-015-0409-0","article-title":"The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity","volume":"22","year":"2016","journal-title":"J Neurovirol"},{"key":"key\n\t\t\t\t20170522125846_CIT0019","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp.62.4.346","article-title":"Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS","volume":"62","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170522125846_CIT0020","doi-asserted-by":"crossref","first-page":"e1000395","DOI":"10.1371\/journal.ppat.1000395","article-title":"Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia","volume":"5","year":"2009","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170522125846_CIT0021","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1016\/S2352-3018(15)00176-9","article-title":"Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial","volume":"2","author":"Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team","year":"2015","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20170522125846_CIT0022","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/jac\/dkw265","article-title":"Virological efficacy of PI monotherapy for HIV-1 in clinical practice","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522125846_CIT0023","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/jac\/dkt517","article-title":"Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group","volume":"69","author":"PIMOCS Study Group","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522125846_CIT0024","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/QAD.0b013e32833db9a1","article-title":"Randomized controlled study demonstrating failure of LPV\/r monotherapy in HIV: the role of compartment and CD4-nadir","volume":"24","author":"Swiss HIV Cohort Study (SHCS)","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522125846_CIT0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3851\/IMP2530","article-title":"Ongoing HIV replication in cerebrospinal fluid under successful monotherapy","volume":"18","year":"2013","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170522125846_CIT0026","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cid\/ciw279","article-title":"Neurocognitive function and neuroimaging markers in virologically suppressed HIV-positive patients randomized to ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional substudy from the PIVOT trial","volume":"63","author":"PIVOT Neurocognitive Substudy Team","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522125846_CIT0027","year":"2016"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/8\/1059\/17353233\/cix035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T01:09:14Z","timestamp":1658538554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,3,13]]},"published-print":{"date-parts":[[2017,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix035","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}